ReviewPlant cell reports2024
Rare earth metallic elements in plants: assessing benefits, risks and mitigating strategies.
Review in Plant cell reports, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
10 citing papers in PubMed.
- AMF-mediated samarium tolerance in Avena sativa: insights into primary metabolism, amino acid biosynthesis, and flavonoid accumulation.BMC plant biology · 2026Article
- Mechanistic Insights into the Differential Toxicity and Antagonistic Interactions of the Rare Earth Elements Cerium and Yttrium Toward Rice Roots.Biological trace element research · 2026Article
- Integrated plant and rhizosphere response to gadolinium exposure in hydroponically grown tomato plants.BMC plant biology · 2026Article
- Screening Bioremediation for the Effective Removal of Regulated and Emerging Contaminants from Mining Wastewater.Molecules (Basel, Switzerland) · 2026Article
- Antiviral nanomedicine: Advantages, mechanisms and advanced therapies.Bioactive materials · 2025Review
- Potentials of typical plant species from rewetted fenlands for the supply of strategic elements.Scientific reports · 2025Article
- Phyto- and Microbial-Based Remediation of Rare-Earth-Element-Polluted Soil.Microorganisms · 2025Review
- The Soil-Plant Continuity of Rare Earth Elements: Insights into an Enigmatic Class of Xenobiotics and Their Interactions with Plant Structures and Processes.Journal of xenobiotics · 2025Review
- Alleviation of salt stress inFrontiers in plant science · 2025Article
- Research potential and mechanism of rare earth elements promoting cadmium remediation efficiency in hyperaccumulator plants.Frontiers in plant science · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Rare earth elements (REEs) comprises of a uniform group of lanthanides and scandium (Sc) and yttrium (Y) finding their key importance in agriculture sectors, electronic and defense industries, and renewable energy production. The immense application of REEs as plant growth promoters has led to their undesirable accumulation in the soil system raising concerns for REE pollution as upcoming stresses. This review mainly addresses the chemistry of REEs, uptake and distribution and their biphasic responses in plant systems and possible plausible techniques that could mitigate/alleviate REE contamination. It extends beyond the present understanding of the biphasic impacts of rare earth elements (REEs) on physio-biochemical attributes. It not only provides landmarks for further exploration of the interrelated phytohormonal and molecular biphasic nature but also introduces novel approaches aimed at mitigating their toxicities. By delving into innovative strategies such as recycling, substitution, and phytohormone-assisted mitigation, the review expands upon existing knowledge of REEs whilst also offering pathways to tackle the challenges associated with REE utilization.
Indexed as
Identifiers
39145796What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.